{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:05:23Z","timestamp":1790949923903,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-18-81"],"award-info":[{"award-number":["320.6750.2024-18-81"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semarthrit.2025.152674","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:21:04Z","timestamp":1740223264000},"page":"152674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study"],"prefix":"10.1016","volume":"72","author":[{"given":"Lizhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semarthrit.2025.152674_bib0001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nephro.2018.11.003","article-title":"Lupus nephritis","volume":"15","author":"Raimbourg","year":"2019","journal-title":"Nephrol Ther"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152674_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2011.04.032","article-title":"Epidemiology and management of refractory lupus nephritis","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0003","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152674_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","article-title":"Systemic lupus erythematosus in children and young people","volume":"23","author":"Charras","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on Lupus nephritis: core Curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152674_bib0006","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.semarthrit.2015.11.013","article-title":"Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts","volume":"45","author":"J\u00f6nsen","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152674_bib0007","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00296-016-3551-y","article-title":"Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study","volume":"36","author":"Chiu","year":"2016","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152674_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40744-021-00368-y","article-title":"The economic burden of Lupus Nephritis: a systematic literature review","volume":"9","author":"Thompson","year":"2022","journal-title":"Rheumatol Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152674_bib0009","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molmed.2018.02.003","article-title":"Mechanisms of tissue injury in Lupus Nephritis","volume":"24","author":"Flores-Mendoza","year":"2018","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152674_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00281-013-0413-5","article-title":"Immunopathology of lupus nephritis","volume":"36","author":"Anders","year":"2014","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","article-title":"Pediatric lupus nephritis","volume":"41","author":"Pinheiro","year":"2019","journal-title":"Jornal brasileiro de nefrologia: 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152674_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pcl.2018.08.007","article-title":"Lupus Nephritis","volume":"66","author":"Wenderfer","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0013","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00467-006-0286-0","article-title":"Clinical outcomes of childhood lupus nephritis: a single center's experience","volume":"22","author":"Lee","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40620-014-0157-x","article-title":"Lupus nephritis in Egyptian children: a 16-year experience","volume":"28","author":"Elmougy","year":"2015","journal-title":"J Nephrol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152674_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semarthrit.2013.07.005","article-title":"Early predictors of outcomes in pediatric lupus nephritis: focus on proliferative lesions","volume":"43","author":"Wu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152674_bib0016","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1681\/ASN.2007121272","article-title":"Successful treatment of class V+IV lupus nephritis with multitarget therapy","volume":"19","author":"Bao","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.semarthrit.2025.152674_bib0018","first-page":"2519","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"358","author":"van den Hoogen","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152674_bib0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/TP.0b013e31821fad06","article-title":"Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation","volume":"92","author":"Ekberg","year":"2011","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152674_bib0020","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/ndt\/gfp778","article-title":"Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study","volume":"25","author":"Ekberg","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0961203319836712","article-title":"Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis","volume":"28","author":"Smith","year":"2019","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152674_bib0022","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5414\/CN109450","article-title":"Maintenance therapy for lupus nephritis with mycophenolate mofetil or azathioprine","volume":"91","author":"Deng","year":"2019","journal-title":"A Meta-Analy Clin Nephrol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0023","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/BOR.0b013e328349a1e5","article-title":"Mycophenolate mofetil in the treatment of systemic lupus erythematosus","volume":"23","author":"Dall'Era","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152674_bib0024","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152674_bib0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/me.2011-0029","article-title":"Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo","volume":"25","author":"Wang","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152674_bib0026","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/rheumatology\/ken335","article-title":"Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis","volume":"47","author":"Szeto","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152674_bib0027","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152674_bib0028","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0961203310389486","article-title":"Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials","volume":"20","author":"Lee","year":"2011","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152674_bib0029","first-page":"6","article-title":"Tacrolimus is effective for lupus nephritis patients with persistent proteinuria","volume":"28","author":"Uchino","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2010.08.036","article-title":"Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trial","volume":"57","author":"Chen","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152674_bib0031","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"4s","key":"10.1016\/j.semarthrit.2025.152674_bib0032","first-page":"S1","article-title":"2021 Clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0033","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152674_bib0034","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2016.12.008","article-title":"Induction and maintenance immunosuppression treatment of proliferative Lupus nephritis: a network meta-analysis of randomized trials","volume":"70","author":"Palmer","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152674_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","article-title":"Tacrolimus use in lupus nephritis: a systematic review and meta-analysis","volume":"15","author":"Hannah","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152674_bib0036","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3906\/sag-1804-57","article-title":"Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials","volume":"48","author":"Deng","year":"2018","journal-title":"Turk J Med Sci"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152674_bib0037","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1681\/ASN.2017030263","article-title":"Multitarget therapy for maintenance treatment of Lupus Nephritis","volume":"28","author":"Zhang","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0038","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-020-04733-x","article-title":"Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis","volume":"36","author":"Godron-Dubrasquet","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"Si2","key":"10.1016\/j.semarthrit.2025.152674_bib0039","doi-asserted-by":"crossref","first-page":"Si180","DOI":"10.1093\/rheumatology\/keae264","article-title":"Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study","volume":"63","author":"Zhang","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2025.152674_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.605060","article-title":"PK\/PD study of mycophenolate mofetil in children with systemic Lupus Erythematosus to inform model-based precision dosing","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152674_bib0041","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.kint.2017.08.031","article-title":"Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis","volume":"93","author":"Fu","year":"2018","journal-title":"Kidney Int"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:49:21Z","timestamp":1767750561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"alternative-id":["S0049017225000459"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152674","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152674"}}